CCBG News Alert Capital City Bank Group (CCBG) 15.25 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Capital City Bank Group (CCBG) 15.25 $CCBG

Quarterly Report Card: New Research on Camden National, Cape Bancorp, Capital Bank Financial, Capital City, and Capitol Federal Financial
PR Newswire - Wed Feb 11, 8:04AM CST
Editor Note: For more information about this release, please scroll to bottom.
CFFN: 12.74 (-0.02), CCBG: 15.25 (+0.06), CBNJ: 8.82 (-0.02), CAC: 38.43 (+0.46), CBF: 26.04 (-0.09)

Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
LCI: 57.78 (-0.91), CCBG: 15.25 (+0.06), IIVI: 17.40 (+0.09), GLW: 25.00 (+0.14), FFIC: 19.85 (-0.08)

Capital City Bank Group, Inc. Reports Fourth Quarter and Full Year 2014 Results
GlobeNewswire - Tue Jan 27, 6:33AM CST
Capital City Bank Group, Inc. (Nasdaq:CCBG) today reported net income of $1.9 million, or $0.11 per diluted share for the fourth quarter of 2014, compared to net income of $2.1 million, or $0.12 per diluted share for the third quarter of 2014, and net income of $2.8 million, or $0.16 per diluted share, for the fourth quarter of 2013. For the full year 2014, the Company reported net income of $9.3 million, or $0.53 per diluted share, compared to net income of $6.0 million, or $0.35 per diluted share in 2013.
CCBG: 15.25 (+0.06)

Capital City Bank misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 6:20AM CST

CCBG: 15.25 (+0.06)

Capital City Bank Group (CCBG) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 23, 7:59AM CST
Capital City Bank Group (CCBG) Sees Hammer Chart Pattern: Time to Buy?
CCBG: 15.25 (+0.06)

Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
ACC: 43.30 (-0.25), CCBG: 15.25 (+0.06), CHGG: 6.44 (-0.06), GLW: 25.00 (+0.14), CAP: 24.72 (-0.61)

Shares of CCBG Up 17.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jan 09, 9:57AM CST
SmarTrend identified an Uptrend for Capital City Bank (NASDAQ:CCBG) on January 17th, 2014 at $12.76. In approximately 12 months, Capital City Bank has returned 17.32% as of today's recent price of $14.97.
CCBG: 15.25 (+0.06)

23.0% Return Seen to Date on SmarTrend Capital City Bank Call (CCBG)
Comtex SmarTrend(R) - Fri Jan 02, 9:21AM CST
SmarTrend identified an Uptrend for Capital City Bank (NASDAQ:CCBG) on January 17th, 2014 at $12.76. In approximately 12 months, Capital City Bank has returned 22.96% as of today's recent price of $15.69.
CCBG: 15.25 (+0.06)

Capital City Bank Has Returned 24.0% Since SmarTrend Recommendation (CCBG)
Comtex SmarTrend(R) - Wed Dec 24, 5:05PM CST
SmarTrend identified an Uptrend for Capital City Bank (NASDAQ:CCBG) on January 17th, 2014 at $12.76. In approximately 11 months, Capital City Bank has returned 23.98% as of today's recent price of $15.82.
CCBG: 15.25 (+0.06)

Uptrend Call Working As Capital City Bank Stock Rises 21.5% (CCBG)
Comtex SmarTrend(R) - Wed Dec 17, 11:08AM CST
SmarTrend identified an Uptrend for Capital City Bank (NASDAQ:CCBG) on January 17th, 2014 at $12.76. In approximately 11 months, Capital City Bank has returned 21.47% as of today's recent price of $15.50.
CCBG: 15.25 (+0.06)

Uptrend Call Working As Capital City Bank Stock Rises 17.7% (CCBG)
Comtex SmarTrend(R) - Wed Dec 10, 9:57AM CST
SmarTrend identified an Uptrend for Capital City Bank (NASDAQ:CCBG) on January 17th, 2014 at $12.76. In approximately 11 months, Capital City Bank has returned 17.71% as of today's recent price of $15.02.
CCBG: 15.25 (+0.06)

17.2% Return Seen to Date on SmarTrend Capital City Bank Call (CCBG)
Comtex SmarTrend(R) - Wed Dec 03, 9:23AM CST
SmarTrend identified an Uptrend for Capital City Bank (NASDAQ:CCBG) on January 17th, 2014 at $12.76. In approximately 11 months, Capital City Bank has returned 17.24% as of today's recent price of $14.96.
CCBG: 15.25 (+0.06)

Capital City Bank declares $0.03 dividend
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 4:16PM CST

CCBG: 15.25 (+0.06)

Capital City Bank Group, Inc. Announces Quarterly Dividend
GlobeNewswire - Tue Nov 25, 4:03PM CST
The Board of Directors of Capital City Bank Group, Inc. (Nasdaq:CCBG) declared a quarterly cash dividend on its common stock of $.03 per share. The dividend, which increased $.01 this quarter, produces an annualized rate of $.12 per common share and is payable on December 22, 2014 to shareowners of record as of December 8, 2014. The annualized dividend yield is .82% based on a closing stock price of $14.71 on November 24, 2014.
CCBG: 15.25 (+0.06)

Capital City Bank Shares Up 14.1% Since SmarTrend's Buy Recommendation (CCBG)
Comtex SmarTrend(R) - Thu Nov 20, 9:52AM CST
SmarTrend identified an Uptrend for Capital City Bank (NASDAQ:CCBG) on January 17th, 2014 at $12.76. In approximately 10 months, Capital City Bank has returned 14.11% as of today's recent price of $14.56.
CCBG: 15.25 (+0.06)

Capital City Bank Named Among "Best Banks to Work For"
GlobeNewswire - Thu Oct 30, 6:30AM CDT
American Banker Magazine has listed Capital City Bank among its 2014 "Best Banks to Work For." Out of 40 banks that achieved best bank status, Capital City Bank ranked #9 overall. The 2014 edition marks the second consecutive year the 119-year-old financial institution has appeared on the list.
CCBG: 15.25 (+0.06)

Capital City Bank EPS in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 6:30AM CDT

CCBG: 15.25 (+0.06)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

JiMMYBAR! Unveils World's First Creatine Trail Mix

Updated Category News Views 3

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Continue Reading
Jaguar Promise Tackles College Cost for Texas Students

Updated Category News Views 3

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Continue Reading
xFusion Tackles Cooling and Power at OCP 2026

Updated Category News Views 4

Bracing for an AI Revolution Ah, the world of AI — it's like the wild west out there, with data centers struggling to keep up as workloads skyrocket. Enter xFusion, a veteran in the computing infrastructure game, rolling out some seriously impressive tech at the 2026 Open Compute Project (OCP) Global Summit. The company's latest offering showcases how they're tackling...

Continue Reading
Puori Protein Transparency Pays Off Amid Lead Scare

Updated Category News Views 5

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 34

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 17

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 6

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 1

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 15

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
WIN Expands Leadership Amidst Rapid Growth Surge

Updated Category News Views 6

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore the New 1 Hotel in Denmark's Capital City

Updated Category News Views 260

Explore the New 1 Hotel in Denmark's Capital City 1 Hotels, known for its commitment to sustainability and luxury, is gearing up to welcome guests to its newest property, 1 Hotel Copenhagen. This highly anticipated urban retreat has opened reservations, inviting travelers to experience a unique blend of nature and urban life. The hotel is set to open soon, transforming...

Continue Reading
Oracle Leverages Google and OpenAI for Cloud Growth

Updated Category Stocks Views 637

Though revenue projections were not met, Oracle's recent financial results show growth in cloud services. Oracle's stock has increased and it is now well-positioned in the cutthroat cloud infrastructure industry thanks to strategic cloud agreements with Google and OpenAI. Using partnerships and database management experience, the company intends to grow its worldwide...

Continue Reading
Heather L. Walter Recognized as Pinnacle Lifetime Member 2026

Updated Category News Views 129

Celebrating Heather L. Walter’s Achievements In a significant acknowledgment, Dr. Heather L. Walter, Ed.D., has been recognized as a 2026 Pinnacle Lifetime Member for her invaluable contributions in the field of special education and educator wellbeing. This honor reflects her unwavering commitment to advancing the standards of education and supporting educators in...

Continue Reading
Amgen's New Drug Trial Results Fall Short for Cancer Patients

Updated Category News Views 253

Amgen's Recent Trial Outcomes for Gastric Cancer Drug Amgen Inc. and its collaborator Zai Lab have revealed the final results of their Phase 3 trial evaluating bemarituzumab when used with the chemotherapy regimen mFOLFOX6 for gastric cancer. This much-anticipated data from the FORTITUDE-101 trial has now completed. Initial Promising Results In the preliminary analysis,...

Continue Reading
Atlantica Sustainable Infrastructure's Major Acquisition Update

Updated Category News Views 226

Atlantica Sustainable Infrastructure's Acquisition Timeline Atlantica Sustainable Infrastructure plc (NASDAQ: AY) is on the verge of a pivotal moment with its acquisition by Energy Capital Partners and co-investors. The expected completion, projected for December 12, 2024, signals a significant evolution for Atlantica as it transitions into a new chapter. The details of...

Continue Reading